FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39296211000001105: Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1840751000001111 Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1840761000001114 Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Is a Sofosbuvir 200mg / Velpatasvir 50mg tablets true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Is a Epclusa true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has specific active ingredient Velpatasvir true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has specific active ingredient Sofosbuvir true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) 28 tablet Has AMP True Epclusa 200mg/50mg tablets (Gilead Sciences Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start